Conference Description
Key Takeaways
- Focuses on digital transformation across the pharmaceutical lifecycle, from drug discovery through regulatory approval and patient delivery
- Addresses practical applications of machine learning in target identification, lead compound design and clinical data interpretation
- Covers real-world data governance, regulatory compliance for digital tools and cybersecurity in pharmaceutical R&D
- Designed for pharmaceutical executives, clinical researchers, data scientists, regulatory professionals and digital health technology developers
About the Event
The Digi-Tech Pharma & AI 2027 Conference, now in its tenth edition, brings together pharmaceutical and biotechnology executives, healthcare technology developers, regulatory authorities and solution providers. The conference examines how digital technologies are reshaping drug development, clinical research and patient care delivery.
Drug Discovery and Development Applications
Sessions address the use of machine learning for target identification and validation, lead compound design and drug combination discovery. The programme includes discussion of quantum computing applications in drug discovery, genomics integration and multi-omics data analytics. Translational medicine data integration and visualization methods are also covered.
Clinical Trials and Real-World Evidence
The conference examines virtual and hybrid clinical trial models alongside digital health strategies for patient-centric trial design. Real-world data features prominently, with sessions on RWD applications in clinical research, regulatory decision-making and patient care improvement. Best practices in real-world data governance are addressed alongside the growing role of real-world evidence in pharmaceutical development.
Data Infrastructure and Emerging Technologies
Topics include FAIR data principles implementation in pharmaceutical R&D, big data applications in precision medicine and healthcare analytics. The programme covers cloud computing adoption, IoT in pharmaceutical operations and blockchain platforms for drug development. Digital therapeutics convergence with traditional pharmaceutical approaches is also explored.
Regulatory and Compliance Considerations
The conference addresses evolving regulatory frameworks for digital pharmaceutical tools, including compliance challenges for machine learning applications. Sessions cover data privacy, integrity and cybersecurity requirements in digital R&D environments. Ethical considerations in algorithm-driven drug discovery, digital audit trails and GxP compliance are examined alongside trust and governance frameworks for digital transformation initiatives.
Who Should Attend
The conference targets VPs, directors, heads and managers across pharmaceutical and biotechnology organizations. Relevant roles include clinical research and drug development professionals, bioinformatics and computational biology specialists, regulatory affairs and quality compliance experts, and pharmacovigilance officers. Data science and analytics professionals, digital transformation leaders, cloud infrastructure architects and cybersecurity specialists will find applicable content. The event also addresses CROs, CDMOs, technology solution providers and investors in pharmaceutical technology.